RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
+12.27%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$913M
AUM Growth
+$136M
(+18%)
Cap. Flow
+$64M
Cap. Flow
% of AUM
7.01%
Top 10 Holdings %
Top 10 Hldgs %
62.19%
Holding
60
New
12
Increased
4
Reduced
12
Closed
4
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$58.3M |
| 2 |
Arbutus Biopharma
ABUS
|
$47.4M |
| 3 |
Ascendis Pharma
ASND
|
$17.8M |
| 4 |
Omeros
OMER
|
$16.5M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$14.9M |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$36.9M |
| 2 |
FWP
Forward Pharma A/S American Depositary Shares
FWP
|
$20.2M |
| 3 |
RGLS
Regulus Therapeutics
RGLS
|
$19.5M |
| 4 |
Novavax
NVAX
|
$15M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$13.9M |
Sector Composition
| 1 | Healthcare | 77.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
51
DELISTED
Celgene Corp
CELG
| $1M | 0.1% |
8,700
| – | – |
|
52
Amgen
AMGN
$151B
| $943K | 0.09% |
5,900
| – | – |
|
53
Acadia Pharmaceuticals
ACAD
$4.32B
| $890K | 0.09% |
27,300
| – | – |
|
|
EIGR
54
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $775K | 0.08% |
91
| – | – |
|
|
KERX
55
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $754K | 0.07% |
59,200
| – | – |
|
56
Puma Biotechnology
PBYI
$250M
| $732K | 0.07% |
3,100
| – | – |
|
|
ISEE
57
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-310,554
| Closed | -$13.9M |
|
|
FWP
58
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| – | – |
-138,657
| Closed | -$20.2M |
|
|
KYTH
59
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| – | – |
-22,750
| Closed | -$789K |
|
|
CTIC
60
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| – | – |
-250,000
| Closed | -$5.9M |
|